Instruments
The following factors were assessed during home visits: weight and height, lung function, and previous CPR or MV. Patients reported comorbidities using the Charlson comorbidity index. [20] Patients' preferences in their current health status for CPR and MV were assessed using two validated questions. [4] In addition, the presence of advance care planning and the preferred site of terminal care were studied.
Patients' life-sustaining treatment preferences were elaborated using the Willingness to Accept Life-sustaining Treatment instrument (WALT), which consists of six scenarios in which patients weigh treatment burden against treatment outcome, expressed in likelihood of different health states and length of life following treatment. [10] , [11] Scenario 1 concerned low-burden therapy and likelihood of death vs return to current health. Scenario 2 concerned low-burden therapy and length of life following therapy. Scenario 3 concerned high-burden therapy and likelihood of death vs return to current health. Scenario 4 concerned high-burden therapy and length of life following therapy. Scenario 5 concerned low-burden therapy and likelihood of functional impairment (being bedbound) vs return to current health. Scenario 6 concerned low-burden therapy and likelihood of cognitive impairment (not recognizing family members) vs return to current health. [11] Quality of communication with the physician specialist was assessed using the Quality of Communication (QOC) questionnaire. [16] , [21] The QOC questionnaire consisted of two domains (general communication and end-of-life care communication). [21] Scores ranged from 0 (worst) to 10 (best). [21] Finally, for each participating patient, the physician specialist was asked to complete a written questionnaire concerning expected prognosis of survival and advance care planning.
Statistics
Statistics were compiled using SPSS, version 17.0 (SPSS, Inc; Chicago, Illinois) and Stata 11.1 (StataCorp LP; College Station, Texas). Categorical variables were described as frequencies, whereas continuous variables were tested for normality and are presented as mean and SD or median and interquartile range. Comparison of continuous variables between patients with COPD and CHF was done using independent sample t tests or Mann-Whitney U tests, as appropriate. Categorical variables were compared between patients with COPD and CHF using χ 2 tests. The influence of general and clinical patient characteristics on preferences regarding CPR and MV was determined using univariate analysis, followed by logistic regression analysis. A log-rank test was used to compare life-sustaining treatment preferences for COPD and CHF for each WALT scenario. To analyze whether and to what extent patients' treatment preferences were influenced by burden of treatment and likelihood of treatment outcome, scenarios 3, 5, and 6 were compared with scenario 1 using a log-rank test. [10] QOC domain scores were compared between patients with COPD and patients with CHF using linear regression analysis, with robust SEs and clustered by physician, while controlling for general and clinical patient characteristics. A priori, a two-sided level of significance was set at P ≤ .05. [22] 
General Patient Characteristics
One hundred five patients with COPD and 80 patients with CHF were included. The proportion of eligible patients who participated in the study was 62.9% for patients with COPD and 46.0% for patients with CHF (P < .05). Chest physicians referred a median of five (one to 10) patients, and cardiologists referred two (one to three) participating patients. Most patients with COPD had very severe COPD (GOLD stage IV, 73.3%). Patients with CHF were classified mainly as NYHA class III (92.5%). On average, patients with CHF were older, had a higher BMI, and were expected to have a worse prognosis of survival compared with patients with COPD ( Table 1) . Unknown 0 (0) [a] 4 (7.8)
Data are presented as mean ± SD or No. (%). CHF = chronic heart failure; LTOT = long-term oxygen therapy; MV = mechanical ventilation; NPPV = noninvasive positive pressure ventilation.
a P < .05 vs CHF.
b Nonparametric statistical tests were used because of skewed data.
c COPD, n = 103; CHF, n = 74.
d COPD, n = 101; CHF, n = 51.
Participating patients were younger than those who refused participation. Moreover, participants with COPD had more advanced disease, whereas participants with CHF were more often men than were nonparticipants. Please see e-Appendix 1 for details.
Preferences Regarding Life-Sustaining Treatments
Preferences Regarding CPR and MV
Most patients reported that they preferred CPR (COPD, 70.5%; CHF, 62.5%; P > .05) and/or MV (COPD, 70.5%; CHF, 66.3%; P > .05). Only a minority of patients were not able to indicate preferences regarding CPR (COPD, 1.9%; CHF, 3.7%; P > .05) or MV (COPD, 3.8%; CHF, 3.7%; P > .05).
Univariate analysis of the relationship of general and clinical patient characteristics with a preference regarding CPR or MV suggested an association between living alone, dependency on personal care, and refusing CPR and/or MV. None of the other patient characteristics shown in Table 1 was related to preference regarding CPR or MV (P ≥ .10). Logistic regression analysis confirmed these findings. Patients who were living alone were more likely to refuse CPR or MV. Furthermore, patients who needed help with personal care were more likely to refuse CPR or MV (Table 2) . Most patients were able to report their treatment preferences according to treatment burden and treatment outcome as assessed with the WALT (Tables 3, 4) . The proportion of patients with COPD or CHF choosing treatment decreased as the likelihood of death or functional or cognitive impairment as the outcome of treatment increased. The proportion of patients choosing treatment did not change when the likelihood of an adverse outcome was < 10% (Table 3 ). In addition, the proportion of patients with COPD or CHF choosing treatment increased when life extension following treatment increased (Table 4) . Patients with CHF were less willing to accept treatment scenario 1 (low-burden/likelihood of death) and scenario 3 (highburden/likelihood of death) than were patients with COPD (P < .05) ( Table 3 ). Other outcomes were comparable between patients with COPD or CHF. The proportion of patients choosing treatment was different for scenario 3 (highburden/likelihood of death) and scenario 6 (low-burden/likelihood of cognitive impairment) compared with scenario 1 (low-burden/likelihood of death) (P < .05 for each comparison) (Fig 1) .
Figure 1
Proportion of patients with COPD or chronic heart failure who accept treatment, according to burden of treatment and likelihood of an adverse outcome. P < .05 for comparison scenario 3 (high burden, death) and scenario 6 (low burden, cognitive impairment) with scenario 1 (low burden, death) (n = 185).
Preferences for Site of Dying
Most patients with COPD (91.4%) and patients with CHF (86.3%) expressed a preferred site for care when they were likely to die. Preferences were comparable for COPD and CHF (Table 5) . No statistically significant differences existed in preference for dying at home according to preference for MV or CPR (P > .05). 
Advance Care Planning
Chest physicians and cardiologists reported communication regarding CPR or MV with 19.8% and 15.7% of their patients, respectively. However, in only 5.9% of the COPD group and 3.9% of CHF group did the patient and physician specialist both report having discussed preferences regarding CPR or MV. The process of dying or palliative care was rarely discussed in both diseases (Table 6 ). Low median scores for end-of-life care communication were given mainly because most patients reported that items concerning end-of-life care were not discussed. Indeed, a majority of the physicians did not address "talking about how long you have to live" (88.6%), "talking about what dying might be like" (88.6%), "asking about spiritual or religious beliefs" (93.4%), "involving you in treatment discussions about your care" (84.9%), and "asking you about important things in life" (83.2%).
The present study shows that the majority of Dutch outpatients with clinically stable severe COPD or CHF are able to indicate their preferences regarding life-sustaining treatments, depending on burden of treatment, outcome of treatment, and likelihood of outcome. Despite the fact that patients can indicate preferences regarding life-sustaining treatments and end-of-life care, these preferences are rarely discussed with their physician specialist. Indeed, patients rate quality of patient-physician end-of-life care communication as low.
The finding that most patients with severe COPD or CHF prefer MV and CPR is in line with previous studies. , [23] However, the present study shows that most patients with severe COPD or CHF do not want highly burdensome interventions with a low likelihood of success. Indeed, the burden of MV or CPR and likelihood of an adverse outcome may be considerable in these patients. [23] , [24] , [25] , [26] Therefore, patients may underestimate their likelihood of an adverse outcome. [27] Because patients' prognosis of survival and life-sustaining treatment preferences are infrequently discussed by their physicians, the reported preferences for CPR and MV probably do not reflect informed and deliberated decisions taking into account treatment burden and likelihood of treatment outcome.
Previously, Fried and colleagues [10] , [11] showed that treatment preferences of patients with COPD, CHF, and cancer with a high probability of death in the next 6 months in the United States were influenced by burden of treatment, outcome of treatment, and likelihood of outcome. In general, patients in the present study had a better estimated prognosis of survival. Only two patients were expected by their physician to die within 6 months. Nevertheless, our study in Dutch outpatients with severe COPD or CHF confirms the findings of Fried and colleagues [10] , [11] and emphasizes again that the complexity of patients' life-sustaining treatment preferences asks for a thorough elaboration of these preferences.
Even though currently available statements regarding palliative care in COPD and CHF recommend advance care planning early in the course of the disease, [2] , [3] this study shows a lack of advance care planning in outpatients with severe COPD or CHF. The general communication skills of physicians are rated high, whereas end-of-life care communication is rated very low. The present QOC questionnaire scores are somewhat lower than those of oxygen-dependent patients with COPD in the United States. [21] The finding that Dutch chest physicians and cardiologists do not address "talking about how long you have to live," "talking about what dying might be like," and "asking about spiritual or religious beliefs" is in line with previous findings in the United States. [16] The fact that prognosis of survival and end-of-life care are rarely discussed may arise from the fact that most physicians overestimate the survival of their patients. [28] Furthermore, physicians may be afraid to take away patients' hope. [29] However, a previous study by Curtis and colleagues [30] has shown that patients and their families differ in their needs and desires for hope and explicit prognostic information. Therefore, patient-physician end-of-life care communication should be tailored to the patient's needs.
Limitations
The study population consists of a convenience sample. Although most eligible patients with COPD were willing to participate, the response rate for patients with CHF was < 50%. It may be possible that eligible patients who refused participation in this study were less willing to discuss issues concerning end-of-life care. The current response rate confirms the previously reported difficulty of recruitment of older patients with CHF [31] and may limit the generalizability of the results.
In addition, there were some small but significant differences between patients with COPD and CHF in some of the scenarios of the WALT. This may be due to differences in general characteristics of patients with COPD or CHF, such as the lower proportion of patients with COPD who were living alone. Other general patient characteristics that differed between COPD and CHF did not show a relationship with life-sustaining treatment preferences.
Patients also receive care from their general practitioner and may have discussed end-of-life care with their general practitioner instead of their physician specialist. This was not assessed in the present study. However, patients had less frequent contact with their general practitioner than with their physician specialist. Therefore, the role of the physician specialist seems to be more prominent in care for the current sample.
Patients who suffer from comorbidities were not excluded from the analyses. In turn, this may have influenced the results of the study. However, comorbidities in patients with COPD or CHF are very common [32] and this increases the general validity of the current findings. Furthermore, preferences regarding CPR or MV did not show a relationship with the presence of comorbidities.
Finally, the present study is a cross-sectional study, and treatment preferences may change during the course of the disease.
[6] , [33] , [34] , [35] A longitudinal follow-up is needed to study change of life-sustaining treatment preferences over time in patients with severe COPD or CHF.
To conclude, the current findings emphasize the lack of advance care planning in Dutch clinically stable outpatients with severe COPD or CHF. Increased awareness among chest physicians and cardiologists that advance care planning is an essential component of care for patients with severe COPD or CHF is necessary. Finally, the quality of patient-physician end-of-life care communication needs to improve.
